Acadian Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-155,070
| Closed | -$505K | – | 2063 |
|
|
2022
Q4 | $505K | Hold |
155,070
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q3 | $455K | Hold |
155,070
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q2 | $382K | Buy |
155,070
+56,223
| +57% | +$261K | ﹤0.01% | 1050 |
|
|
2022
Q1 | $797K | Buy |
98,847
+6,010
| +6% | +$61.4K | ﹤0.01% | 880 |
|
|
2021
Q4 | $1.23M | Buy |
92,837
+85,041
| +1,091% | +$2.14M | ﹤0.01% | 779 |
|
|
2021
Q3 | $339K | Buy |
7,796
+5,769
| +285% | +$249K | ﹤0.01% | 1157 |
|
|
2021
Q2 | $85K | Buy |
+2,027
| New | +$89.1K | ﹤0.01% | 1676 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | – | – | 2402 |
|
|
2020
Q3 | $0 | Sell |
3
-490
| -99% | -$42.8K | ﹤0.01% | 2436 |
|
|
2020
Q2 | $52K | Buy |
493
+490
| +16,333% | +$58.2K | ﹤0.01% | 1909 |
|
|
2020
Q1 | $0 | Sell |
3
-1,273
| -100% | -$152K | ﹤0.01% | 1997 |
|
|
2019
Q4 | $145K | Sell |
1,276
-941
| -42% | -$70.8K | ﹤0.01% | 1366 |
|
|
2019
Q3 | $137K | Sell |
2,217
-1,845
| -45% | -$148K | ﹤0.01% | 1405 |
|
|
2019
Q2 | $317K | Buy |
4,062
+1,206
| +42% | +$137K | ﹤0.01% | 1122 |
|
|
2019
Q1 | $385K | Buy |
2,856
+2,259
| +378% | +$237K | ﹤0.01% | 1181 |
|
|
2018
Q4 | $48K | Sell |
597
-1,817
| -75% | -$179K | ﹤0.01% | 1433 |
|
|
2018
Q3 | $253K | Buy |
2,414
+333
| +16% | +$31.7K | ﹤0.01% | 1035 |
|
|
2018
Q2 | $208K | Sell |
2,081
-1,571
| -43% | -$178K | ﹤0.01% | 1077 |
|
|
2018
Q1 | $460K | Buy |
3,652
+2,568
| +237% | +$400K | ﹤0.01% | 882 |
|
|
2017
Q4 | $181K | Buy |
1,084
+1,005
| +1,272% | +$257K | ﹤0.01% | 977 |
|
|
2017
Q3 | $25K | Sell |
79
-11,619
| -99% | -$3.67M | ﹤0.01% | 1190 |
|
|
2017
Q2 | $3.47M | Buy |
11,698
+10,047
| +609% | +$2.69M | 0.02% | 459 |
|
|
2017
Q1 | $381K | Buy |
+1,651
| New | +$285K | ﹤0.01% | 944 |
|
Other funds holding CALA
Acadian Asset Management's CALA Position: Q1 2023 in Review
Acadian Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 155,070 shares — an estimated $505K sold.
Acadian Asset Management first reported a position in CALA in Q1 2017 and held it in 22 quarters. The position peaked at $3.47M in Q2 2017. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Acadian Asset Management reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Acadian Asset Management sold 155,070 Calithera Biosciences, Inc shares in Q1 2023, an estimated $505K.
- Acadian Asset Management first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 22 quarters.
- Acadian Asset Management's Calithera Biosciences, Inc position peaked at $3.47M in Q2 2017.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.